We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gottlieb: FDA Considering User Fees for Generics
Gottlieb: FDA Considering User Fees for Generics
March 29, 2006
A top FDA official said the agency is interested in exploring user fees for generic drug companies — a move that comes as the FDA’s generics division faces a backlog of applications and is slated for virtually flat funding in fiscal 2007.